Skip to main content
TipRanks
Go Ultimate75% OFF

TaiMed Biologics Inc. (4147) Q4 2023 Earnings Report

TW:4147 Q4 2023 EPS Results

Actual EPS
-TWD 0.08
Consensus EPS
-TWD 0.15
Beat/Miss
Beat by +TWD 0.07
One Year Ago EPS
-TWD 0.15

TW:4147 Q4 2023 Revenue Results

Actual Revenue
TWD 158.22M
Expected Revenue
TWD 120.00M
Beat/Miss
Beat by +TWD 38.22M
YoY Revenue Growth
-51.54%

Earnings Announcement Details

Quarter
Q4 2023
Date
03/14/2024
Time
Before Open
Conference Call
Thursday, March 14, 2024

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

TW:4147 Earnings History

TW:4147 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 18, 20262026 (Q3)-0.29-0.14-0.05-182.35% (-0.09)
May 07, 20262026 (Q1)-0.230.06-0.09163.83% (+0.15)
Mar 03, 20262025 (Q4)―-0.25-0.4544.22% (+0.20)
Nov 05, 20252025 (Q3)―-0.05-0.1463.57% (+0.09)
Aug 07, 20252025 (Q2)-0.05-0.22-0.1-118.00% (-0.12)
May 08, 20252025 (Q1)-0.15-0.09-0.06-49.21% (-0.03)
Mar 12, 20252024 (Q4)-0.16-0.45-0.08-469.62% (-0.37)
Nov 13, 20242024 (Q3)-0.17-0.14-0.02-600.00% (-0.12)
Aug 14, 20242024 (Q2)-0.06-0.10-0.1946.52% (+0.09)
May 15, 20242024 (Q1)-0.17-0.06-0.3280.00% (+0.25)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed